Results 151 to 160 of about 33,753 (206)

Impact of Short-Term Exposure to Nitrogen Dioxide (NO₂) and Ozone (O₃) on Hospital Admissions for Non-ST-Segment Elevation Acute Coronary Syndrome. [PDF]

Toxics
Rus AA, Pescariu SA, Zus AS, Gaiţă D, Mornoş C.   +4 more
europepmc   +1 more source

Safety and efficacy of PCSK9 inhibitor (evolocumab) in patients with non-ST segment elevation acute coronary syndrome and non-culprit artery critical lesions: a randomised controlled trial protocol (SPECIAL study). [PDF]

BMJ Open
Wang YW, Xu J, Ma L, Hu H, Chen HW, Hua JS, Kong XY, Li D, Li LW, Pan JY, Wu J.   +10 more
europepmc   +1 more source

Correlation and consistency between resting full-cycle ratio and fractional flow reserve in assessing coronary artery function in a Chinese real-world cohort with non-ST-segment elevation acute coronary syndrome: a retrospective observational study. [PDF]

BMJ Open
Lei Y, Liu X, Jiang M, Li M, Zhang S, Wang Y, Chen M, Guo N, Liu Y, Cao X, Yan L.   +10 more
europepmc   +1 more source

Management of non ST segment elevation acute coronary syndromes: A shift in the paradigm

Chinese Medical Journal, 2008
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

ST2 and mortality in non–ST-segment elevation acute coronary syndrome

American Heart Journal, 2010
ST2 is a member of the interleukin-1 receptor family that is up-regulated in conditions associated with increased myocardial strain. ST2 has been shown to be independently predictive of adverse outcome in heart failure and ST-segment elevation myocardial infarction, but its prognostic value in non-ST-elevation acute coronary syndrome (NSTE-ACS) has not
Eggers, KM, Armstrong, PW, Califf, RM, Simoons, Maarten, Venge, P, Wallentin, L, James, SK   +6 more
openaire   +3 more sources

Non-ST-segment elevation acute coronary syndromes

2021
Non-ST-segment elevation acute coronary syndromes are potentially life-threatening disorders, usually caused by acute coronary thrombosis and subsequent myocardial ischaemia, presenting without persistent ST-segment elevation in the initial electrocardiogram.
Héctor Bueno, José A Barrabés
openaire   +1 more source

Anticoagulation in the Management of Non-ST-Segment Elevation Acute Coronary Syndrome

Journal of Pharmacy Practice, 2010
There are currently over 1 million patients admitted to hospitals in the United States with the diagnosis of non-ST-segment elevation acute coronary syndrome (NSTE ACS). Due to the significant morbidity and mortality associated with NSTE ACS, appropriate use of the numerous medications employed is critical in ensuring optimal outcomes.
Paul P, Dobesh, Toby C, Trujillo
openaire   +2 more sources

Non-ST Segment Elevation Acute Coronary Syndromes: A Comprehensive Review

Southern Medical Journal, 2006
As the non-ST segment elevation acute coronary syndromes (NSTEACS) include unstable angina pectoris (UAP) and the non-ST segment elevation myocardial infarction (NSTEMI), acute diagnosis and risk stratification can often prove challenging. This review will cover guidelines and strategies for risk assessment, contemporary approaches to acute patient ...
Abelardo, Martinez-Rumayor, James L, Januzzi   +1 more
openaire   +2 more sources